Short Interest in Sonova Holding (OTCMKTS:SONVY) Expands By 657.2%

Sonova Holding (OTCMKTS:SONVY) was the recipient of a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 11,418 shares, a growth of 657.2% from the July 15th total of 1,508 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 23,205 shares, the days-to-cover ratio is currently 0.5 days.

Sonova Stock Performance

SONVY opened at $58.61 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. Sonova has a 12-month low of $42.26 and a 12-month high of $61.09. The business’s fifty day simple moving average is $51.76 and its 200-day simple moving average is $49.91.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. UBS Group raised shares of Sonova from a “hold” rating to a “buy” rating in a research note on Wednesday, July 22nd. Citigroup reissued a “sell” rating on shares of Sonova in a research report on Friday, July 24th. Finally, Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a research note on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Sonova currently has a consensus rating of “Hold”.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.